Inventor
KIM JOSEPH L
US64 patents
⚠️ This page may combine multiple inventors who share the name “KIM JOSEPH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
25 patentsUS9944651B2Apr 17, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP33 citations98
US9340514B2May 17, 2016
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP43 citations97
US10584114B2Mar 10, 2020
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations94
US10202365B2Feb 12, 2019
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP20 citations94
US10030005B2Jul 24, 2018
Inhibitors of RET
BLUEPRINT MEDICINES CORP38 citations94
US9994575B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP32 citations94
US9994552B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP31 citations94
US9884861B2Feb 6, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP32 citations94
US10233186B2Mar 19, 2019
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP16 citations93
US11279688B2Mar 22, 2022
Inhibitors of RET
BLUEPRINT MEDICINES CORP5 citations84
US10774070B2Sep 15, 2020
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP6 citations84
US10183928B2Jan 22, 2019
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations84
US10378063B2Aug 13, 2019
RAF1 fusions
BLUEPRINT MEDICINES CORP8 citations82
US11827642B2Nov 28, 2023
Compositions useful for treating disorders related to KIT
BLUEPRINT MEDICINES CORP2 citations73
US11534441B2Dec 27, 2022
MAP4K1 inhibitors
BLUEPRINT MEDICINES CORP3 citations72
US11970498B2Apr 30, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations71
US11718602B2Aug 8, 2023
EGFR inhibitors
BLUEPRINT MEDICINES CORP2 citations70
US11634422B2Apr 25, 2023
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations70
US11236086B2Feb 1, 2022
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations62
US11040979B2Jun 22, 2021
Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
BLUEPRINT MEDICINES CORP0 citations62
US10370379B2Aug 6, 2019
Compounds and compositions useful for treating disorders related to NTRK
BLUEPRINT MEDICINES CORP1 citations62
US12545684B2Feb 10, 2026
CDK2 inhibitors
BLUEPRINT MEDICINES CORP0 citations61
US12042495B2Jul 23, 2024
MAP4K1 inhibitors
BLUEPRINT MEDICINES CORP1 citations61
US11932648B2Mar 19, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations61
US11261497B2Mar 1, 2022
PRKC fusions
BLUEPRINT MEDICINES CORP0 citations61
AMGEN INC
13 patentsUS7282504B2Oct 16, 2007
Kinase inhibitors
AMGEN INC90 citations97
US6878714B2Apr 12, 2005
Substituted alkylamine derivatives and methods of use
AMGEN INC85 citations97
US6995162B2Feb 7, 2006
Substituted alkylamine derivatives and methods of use
AMGEN INC48 citations95
US7435823B2Oct 14, 2008
Compounds and methods of use
AMGEN INC19 citations92
US7105682B2Sep 12, 2006
Substituted amine derivatives and methods of use
AMGEN INC29 citations92
US7074789B2Jul 11, 2006
Kinase inhibitors
AMGEN INC25 citations92
US7880000B2Feb 1, 2011
Protein kinase modulators and method of use
AMGEN INC21 citations91
US7531553B2May 12, 2009
Heterocyclic compounds and methods of use
AMGEN INC44 citations91
US7514564B2Apr 7, 2009
Substituted amine derivatives and methods of use
AMGEN INC16 citations83
US7101868B2Sep 5, 2006
Substituted arylamine derivatives and methods of use
AMGEN INC20 citations83
US6881737B2Apr 19, 2005
Substituted triazinyl acrylamide derivatives and methods of use
AMGEN INC8 citations73
US6864255B2Mar 8, 2005
Substituted triazinyl amide derivatives and methods of use
AMGEN INC10 citations73
US8017601B2Sep 13, 2011
Bis-aryl kinase inhibitors and method
AMGEN INC7 citations71
VERTEX PHARMA
5 patentsUS6183121B1Feb 6, 2001
Hepatitis C virus helicase crystals and coordinates that define helicase binding pockets
VERTEX PHARMA61 citations95
US5978740ANov 2, 1999
Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them
VERTEX PHARMA45 citations93
US6303287B1Oct 16, 2001
Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
VERTEX PHARMA19 citations90
US6153579ANov 28, 2000
Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
VERTEX PHARMA26 citations90
US7438920B1Oct 21, 2008
Crystals of hepatitis C virus helicase or fragments thereof comprising a helicase binding pocket
VERTEX PHARMA21 citations89
HODOUS BRIAN L
2 patentsBIFULCO JR NEIL
2 patentsDIPIETRO LUCIAN V
1 patentGEUNS-MEYER STEPHANIE D
1 patentCHEN GUOQING
1 patentShowing the top 50 of 64 patents by PatentIndex Score.